AMZN
Amazon.com, Inc.
AMZN has the edge over KRUS overall, supported by lower modeled downside and stronger valuation.
KRUS
Kura Sushi USA, Inc.
KRUS's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
KRUS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Healthy |
KRUS's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
KRUS PE Valuation
KRUS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 285x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
KRUS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect KRUS to return to profit, with revenue growing. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over KRUS on earnings quality, reporting a profit while its opponent remains loss making.
KRUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.09 | — |
| Q3 2026 | -$0.38 | -$0.22 |
| Q2 2026 | -$0.18 | +$0.63 |
| Q1 2026 | -$0.16 | +$0.75 |
| Q4 2025 | -$0.33 | +$0.36 |
| Q3 2025 | -$0.16 | +$0.63 |
| Q2 2025 | -$0.81 | -$0.78 |
| Q1 2025 | -$0.91 | -606% |
| Q4 2024 | -$0.69 | -506% |
KRUS is still losing money, but far less than before: $0.38 per share over the past year, against $0.91 at its worst in early 2025.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over KRUS on profitability, with a higher operating margin.
KRUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $88.9M | +12% |
| Q2 2026 | $85.9M | +16% |
| Q1 2026 | $80M | +23% |
| Q4 2025 | $73.5M | +14% |
| Q3 2025 | $79.4M | +20% |
| Q2 2025 | $74M | +17% |
| Q1 2025 | $64.9M | +13% |
| Q4 2024 | $64.5M | +25% |
KRUS has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.7% | -2.6 points |
| Q2 2026 | -0.1% | +0.2 points |
| Q1 2026 | -2.8% | +4.3 points |
| Q4 2025 | -5% | -2.7 points |
| Q3 2025 | 1.8% | +11 points |
| Q2 2025 | -0.2% | +1.6 points |
| Q1 2025 | -7.1% | -4.1 points |
| Q4 2024 | -2.3% | +3.2 points |
KRUS's operating margin was −0.7% last quarter, down 2.6 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
KRUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$244K | -$165K |
| Q2 2026 | -$3.7M | +$3.2M |
| Q1 2026 | -$7.9M | -$576K |
| Q4 2025 | -$13.3M | -$6.1M |
| Q3 2025 | -$79K | +$9.5M |
| Q2 2025 | -$6.9M | -$4.5M |
| Q1 2025 | -$7.3M | +$2.4M |
| Q4 2024 | -$7.2M | -$226K |
KRUS has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over KRUS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
KRUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -227K shares |
| 1 year | +1.8% | +216K shares |
| 3 years | +14% | +1.5M shares |
KRUS has 12M diluted shares, up 1.8% from a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
KRUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.6x | Net Cash |
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -2.4x | Net Cash |
| Q4 2025 | -4.4x | Net Cash |
| Q3 2025 | -5.1x | Net Cash |
| Q2 2025 | -35.0x | Net Cash |
| Q4 2024 | -48.1x | Net Cash |
| Q3 2024 | -188.8x | Net Cash |
KRUS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
KRUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.5 | Neutral |
| Stochastic | 9.0 | Oversold |
KRUS's weekly RSI is 34 (neutral) and its Stochastic is 9 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
KRUS PE vs Consumer Cyclical Sector
| Metric | KRUS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
KRUS has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over KRUS on trend strength, trading above more of its moving averages.
KRUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.9 | 24% below |
| 20 week MA | $42.1 | 37% below |
| 50 week MA | $52.8 | 50% below |
| 100 week MA | $61.1 | 57% below |
| 200 week MA | $71.1 | 63% below |
KRUS is in a downtrend: it's below all five of its weekly moving averages, and 63% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over KRUS on returns for 2026, with the stronger performance.
KRUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.1 | $18.9 | -30% |
| 2021 | $18.9 | $78.0 | +312% |
| 2022 | $78.0 | $51.1 | -35% |
| 2023 | $51.1 | $76.0 | +49% |
| 2024 | $76.0 | $90.2 | +19% |
| 2025 | $90.2 | $56.4 | -37% |
| 2026 YTD | $56.4 | $26.5 | -53% |
KRUS has finished lower in three of the last six years. It's down 53% so far in 2026.